Found: 8
Select item for more details and to access through your institution.
Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation.
- Published in:
- EMBO Journal, 2021, v. 40, n. 7, p. 1, doi. 10.15252/embj.2020106151
- By:
- Publication type:
- Article
Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma.
- Published in:
- Histopathology, 2023, v. 83, n. 6, p. 912, doi. 10.1111/his.15034
- By:
- Publication type:
- Article
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers.
- Published in:
- Histopathology, 2021, v. 78, n. 6, p. 896, doi. 10.1111/his.14306
- By:
- Publication type:
- Article
SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum.
- Published in:
- Histopathology, 2020, v. 77, n. 2, p. 231, doi. 10.1111/his.14110
- By:
- Publication type:
- Article
Microscopic size measurements in post‐neoadjuvant therapy resections of pancreatic ductal adenocarcinoma (PDAC) predict patient outcomes.
- Published in:
- Histopathology, 2020, v. 77, n. 1, p. 144, doi. 10.1111/his.14067
- By:
- Publication type:
- Article
Loss of expression of MLH1 in non‐dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps.
- Published in:
- Histopathology, 2019, v. 75, n. 3, p. 376, doi. 10.1111/his.13874
- By:
- Publication type:
- Article
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182855
- By:
- Publication type:
- Article